Keraceuticals, Inc.
San Antonio, TX
- UEI
- C7XZAGG5ZHL3
- CAGE
- 9FAY3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 8810 Drayton Heights, San Antonio, TX 78254, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 1,3-thioureas as first in class mitochondrial inhibitors to treat oral cancer - abstract keraceuticals is developing a… | National Institute of Dental and Craniofacial Research | $799,270 |
Quick answers
What is Keraceuticals, Inc.'s UEI?
Keraceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is C7XZAGG5ZHL3.
What is Keraceuticals, Inc.'s CAGE code?
Keraceuticals, Inc.'s CAGE code is 9FAY3.
What is Keraceuticals, Inc.'s primary NAICS code?
Keraceuticals, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Keraceuticals, Inc. located?
Keraceuticals, Inc.'s physical address in SAM.gov is 8810 Drayton Heights, San Antonio, TX 78254, USA.
Is Keraceuticals, Inc. registered in SAM.gov?
Yes. Keraceuticals, Inc.'s SAM.gov registration is active through July 14, 2027.
What is Keraceuticals, Inc.'s most recent federal award?
Keraceuticals, Inc.'s most recent federal grant award is 1,3-thioureas as first in class mitochondrial inhibitors to treat oral cancer - abstract keraceuticals is developing a… (R41DE034719), from National Institute of Dental and Craniofacial Research, on September 25, 2024.
On GovTribe
See Keraceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors